Coloplast Presents Revised 2030 Ambition for 5-7% Annual Organic Growth

By Public Technologies
  • Coloplast revised its 2030 ambitions to 5-7% annual organic growth and a mid-20% EBIT margin in constant currencies, before special items.
  • Higher growth investments and external headwinds underpin the revision; a cost-saving program targets DKK 500 million, fully effective in FY 2027/28.
  • FY 2026/27 guidance calls for 5-7% organic growth and an EBIT margin around 25% in constant currencies, before special items.
  • FY 2025/26 revenue rose 4% to DKK 28.94 billion, with organic growth of 6%.
  • EBIT before special items fell 3% to DKK 7.45 billion; the reported margin narrowed to 26% from 28%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coloplast A/S published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.